LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 85

Search options

  1. Book: Peripheral, head and neck surgery

    Coventry, Brendon J.

    (Surgery : complications, risks and consequences)

    2014  

    Author's details Brendon J. Coventry ed
    Series title Surgery : complications, risks and consequences
    Language English
    Size XXI, 149 S. : Ill.
    Publisher Springer
    Publishing place London u.a.
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT018153551
    ISBN 978-1-4471-5414-3 ; 1-4471-5414-2 ; 9781447154150 ; 1447154150
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book: Pediatric surgery

    Coventry, Brendon J.

    (Surgery : complications, risks and consequences)

    2014  

    Author's details Brendon J. Coventry ed
    Series title Surgery : complications, risks and consequences
    Language English
    Size XXI, 205 S.
    Publisher Springer
    Publishing place London u.a.
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT017762174
    ISBN 978-1-4471-5438-9 ; 1-4471-5438-X ; 9781447154396 ; 1447154398
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  3. Book: Upper abdominal surgery

    Coventry, Brendon J.

    (Surgery : complications, risks and consequences)

    2014  

    Author's details Brendon J. Coventry ed
    Series title Surgery : complications, risks and consequences
    Language English
    Size XXI, 229 S. : Ill., graph. Darst.
    Publisher Springer
    Publishing place London u.a.
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT017762301
    ISBN 978-1-4471-5435-8 ; 1-4471-5435-5 ; 9781447154365 ; 1447154363
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  4. Book: General surgery risk reduction

    Coventry, Brendon J.

    (Surgery: complications, risks and consequences)

    2014  

    Author's details Brendon J. Coventry ed
    Series title Surgery: complications, risks and consequences
    Language English
    Size XXII, 345 S. : Ill., graph. Darst.
    Publisher Springer
    Publishing place London u.a.
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT018157863
    ISBN 978-1-4471-5390-0 ; 9781447153917 ; 1-4471-5390-1 ; 144715391X
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  5. Book: Breast, endocrine and surgical oncology

    Coventry, Brendon J.

    (Surgery: complications, risks and consequences)

    2014  

    Author's details Brendon J. Coventry ed
    Series title Surgery: complications, risks and consequences
    Language English
    Size XXII, 237 S. : Ill., grapj. Darst.
    Publisher Springer
    Publishing place London u.a.
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT018157517
    ISBN 978-1-4471-5420-4 ; 9781447154211 ; 1-4471-5420-7 ; 1447154215
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  6. Book: Lower abdominal and perineal surgery

    Coventry, Brendon J.

    (Surgery : complications, risks and consequences)

    2014  

    Author's details Brendon J. Coventry ed
    Series title Surgery : complications, risks and consequences
    Language English
    Size XXI, 136 S. : Ill.
    Publisher Springer
    Publishing place London u.a.
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT017762288
    ISBN 978-1-4471-5468-6 ; 1-4471-5468-1 ; 9781447154693 ; 144715469X
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  7. Article: Therapeutic vaccination immunomodulation: forming the basis of all cancer immunotherapy.

    Coventry, Brendon J

    Therapeutic advances in vaccines and immunotherapy

    2019  Volume 7, Page(s) 2515135519862234

    Abstract: Recent immunotherapy advances have convincingly demonstrated complete tumour removal with long-term survival. These impressive clinical responses have rekindled enthusiasm towards immunotherapy and tumour antigen vaccination providing 'cures' for ... ...

    Abstract Recent immunotherapy advances have convincingly demonstrated complete tumour removal with long-term survival. These impressive clinical responses have rekindled enthusiasm towards immunotherapy and tumour antigen vaccination providing 'cures' for melanoma and other cancers. However, many patients still do not benefit; sometimes harmed by severe autoimmune toxicity. Checkpoint inhibitors (anti-CTLA4; anti-PD-1) and interleukin-2 (IL-2) are 'pure immune drivers' of pre-existing immune responses and can induce either desirable effector-stimulatory or undesirable inhibitory-regulatory responses. Why some patients respond well, while others do not, is presently unknown, but might be related to the cellular populations being 'driven' at the time of dosing, dictating the resulting immune response. Vaccination is in-vivo immunotherapy requiring an active host response. Vaccination for cancer treatment has been skeptically viewed, arising partially from difficulty demonstrating clear, consistent clinical responses. However, this article puts forward accumulating evidence that 'vaccination' immunomodulation constitutes the fundamental, central, intrinsic property associated with antigen exposure not only from exogenous antigen (allogeneic or autologous) administration, but also from endogenous release of tumour antigen (autologous) from in-vivo tumour-cell damage and lysis. Many 'standard' cancer therapies (chemotherapy, radiotherapy etc.) create waves of tumour-cell damage, lysis and antigen release, thus constituting 'in-vivo vaccination' events. In essence, whenever tumour cells are killed, antigen release can provide in-vivo repeated vaccination events. Effective anti-tumour immune responses require antigen release/supply; immune recognition, and immune responsiveness. With better appreciation of endogenous vaccination and immunomodulation, more refined approaches can be engineered with prospect of higher success rates from cancer therapy, including complete responses and better survival rates.
    Language English
    Publishing date 2019-08-01
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2970613-0
    ISSN 2515-1363 ; 2515-1355
    ISSN (online) 2515-1363
    ISSN 2515-1355
    DOI 10.1177/2515135519862234
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Increased Early Cancer Diagnosis: Unveiling Immune-Cancer Biology to Explain Clinical "Overdiagnosis".

    Wauchope, Bruce A / Coventry, Brendon J / Roder, David M

    Cancers

    2023  Volume 15, Issue 4

    Abstract: Even though clinically small 'early' cancers represent many millions of cells biologically, when removed surgically, these often never recur or regrow, nor reduce the individual's lifespan. However, some early cancers remain quiescent and indolent; while ...

    Abstract Even though clinically small 'early' cancers represent many millions of cells biologically, when removed surgically, these often never recur or regrow, nor reduce the individual's lifespan. However, some early cancers remain quiescent and indolent; while others grow and metastasize, threatening life. Distinguishing between these different clinical behaviours using clinical/pathological criteria is currently problematic. It is reported that many suspicious lesions and early cancers are being removed surgically that would not threaten the patient's life. This has been termed 'overdiagnosis', especially in the sphere of cancer screening. Although a controversial and emotive topic, it poses clinical and public health policy challenges. The diagnostic differentiation between 'non-lethal' and 'lethal' tumor forms is generally impossible. One perspective gathering evidential support is that a dynamic balance exists between the immune response and malignant processes governing 'lethality', where many more cancers are produced than become clinically significant due to the immune system preventing their progression. Higher medical screening "diagnosis" rates may reflect lead-time effects, with more 'non-progressing' cancers detected when an early immune-cancer interaction is occurring. We present a model for this immune-cancer interaction and review 'excess' or 'overdiagnosis' claims that accompany increasingly sensitive diagnostic and screening technologies. We consider that immune tools should be incorporated into future research, with potential for immune system modulation for some early cancers.
    Language English
    Publishing date 2023-02-10
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers15041139
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The Immune System and Responses to Cancer

    Brendon J. Coventry / Maciej Henneberg

    F1000Research, Vol

    Coordinated Evolution [version 3; peer review: 2 approved]

    2021  Volume 4

    Abstract: This review explores the incessant evolutionary interaction and co-development between immune system evolution and somatic evolution, to put it into context with the short, over 60-year, detailed human study of this extraordinary protective system. Over ... ...

    Abstract This review explores the incessant evolutionary interaction and co-development between immune system evolution and somatic evolution, to put it into context with the short, over 60-year, detailed human study of this extraordinary protective system. Over millions of years, the evolutionary development of the immune system in most species has been continuously shaped by environmental interactions between microbes, and aberrant somatic cells, including malignant cells. Not only has evolution occurred in somatic cells to adapt to environmental pressures for survival purposes, but the immune system and its function has been successively shaped by those same evolving somatic cells and microorganisms through continuous adaptive symbiotic processes of progressive simultaneous immunological and somatic change to provide what we observe today. Indeed, the immune system as an environmental influence has also shaped somatic and microbial evolution. Although the immune system is tuned to primarily controlling microbiological challenges for combatting infection, it can also remove damaged and aberrant cells, including cancer cells to induce long-term cures. Our knowledge of how this occurs is just emerging. Here we consider the connections between immunity, infection and cancer, by searching back in time hundreds of millions of years to when multi-cellular organisms first began. We are gradually appreciating that the immune system has evolved into a truly brilliant and efficient protective mechanism, the importance of which we are just beginning to now comprehend. Understanding these aspects will likely lead to more effective cancer and other therapies.
    Keywords developmental evolution ; genetics of the immune system ; Medicine ; R ; Science ; Q
    Subject code 006
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher F1000 Research Ltd
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Cutaneous malignant melanoma incidence is strongly associated with European depigmented skin type regardless of ambient ultraviolet radiation levels: evidence from Worldwide population-based data.

    You, Wenpeng / Henneberg, Renata / Coventry, Brendon J / Henneberg, Maciej

    AIMS public health

    2022  Volume 9, Issue 2, Page(s) 378–402

    Abstract: Current public health advice is that high ultraviolet radiation (UVR) exposure is the primary cause of Malignant Melanoma of skin (CMM), however, despite the use of sun-blocking products incidence of melanoma is increasing. To investigate the UVR ... ...

    Abstract Current public health advice is that high ultraviolet radiation (UVR) exposure is the primary cause of Malignant Melanoma of skin (CMM), however, despite the use of sun-blocking products incidence of melanoma is increasing. To investigate the UVR influence on CMM incidence worldwide WHO, United Nations, World Bank databases and literature provided 182 country-specific melanoma incidence estimates, daily UVR levels, skin colour (EEL), socioeconomic status (GDP PPP), magnitude of reduced natural selection (Ibs), ageing, urbanization, percentage of European descendants (Eu%), and depigmentation (blonde hair colour), for parametric and non-parametric correlations, multivariate regressions and analyses of variance. Worldwide, UVR levels showed negative correlation with melanoma incidence ("rho" = -0.515, p < 0.001), remaining significant and negative in parametric partial correlation (r = -0.513, p < 0.001) with other variables kept constant. After standardising melanoma incidence for Eu%, melanoma correlation with UVR disappeared completely ("rho" = 0.004, p = 0.967, n = 127). The results question classical views that UVR causes melanoma. No correlation between UVR level and melanoma incidence was present when Eu% (depigmented or light skin type) was kept statistically constant, even after adjusting for other known variables. Countries with lower UVR levels and more Eu% (depigmented or light skin people) have higher melanoma incidence. Critically, this means that individual genetic low skin pigmentation factors predict melanoma risk regardless of UVR exposure levels, and even at low-UVR levels.
    Language English
    Publishing date 2022-03-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2777115-5
    ISSN 2327-8994 ; 2327-8994
    ISSN (online) 2327-8994
    ISSN 2327-8994
    DOI 10.3934/publichealth.2022026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top